GlassScriptPhysician profile
Harjit S Athwal
NPI 1396732491
$7,118.20
in general payments reported to CMS, 2019-2025
36 companies · $1,387 in 2025
The $1,387 reported for 2025 was more than what 84% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $686 · 2020: $701 · 2021: $1,069 · 2022: $896 · 2023: $582 · 2024: $1,797 · 2025: $1,387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,766.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $866.25 | 2019-2025 | Clareon, Tryptyr, Rocklatan |
| Sun Pharmaceutical Industries INC. | $716.21 | 2019-2025 | Cequa |
| Johnson & Johnson Surgical Vision, INC. | $696.93 | 2019-2024 | Veritas Vision System, Tecnis Iol |
| Biotissue Holdings INC. | $484.82 | 2019-2025 | |
| Allergan, INC. | $469.58 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $467.11 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $449.85 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Kala Pharmaceuticals, INC. | $370.82 | 2020-2022 | |
| Oyster Point Pharma, INC. | $365.12 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Dompe US, INC. | $332.51 | 2019-2025 | Oxervate |
| Abbvie INC. | $254.49 | 2022-2025 | Lumigan, Alphagan P |
| Ocular Therapeutix, INC. | $161.34 | 2019-2025 | Dextenza |
| Rxsight INC | $147.19 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $141.17 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $140.27 | 2019-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $125.62 | 2020-2023 | Omni Surgical System |
| Harrow Eye, LLC | $113.57 | 2023-2025 | Vevye, Iheezo |
| New World Medical,INC. | $97.48 | 2024 | Ahmed Glaucoma Valve, Kahook Dual Blade, Clearpath |
| Aerie Pharmaceuticals, INC. | $85.46 | 2019-2021 | |
| Thea Pharma INC. | $84.92 | 2023-2025 | Iyuzeh |
| Boston Scientific Corporation | $82.55 | 2020 | |
| Apellis Pharmaceuticals, INC. | $76.14 | 2023-2025 | Syfovre |
| Mallinckrodt Hospital Products INC. | $68.29 | 2021-2022 | |
| Eyevance Pharmaceuticals LLC | $37.40 | 2019-2022 | |
| Ani Pharmaceuticals, INC. | $34.98 | 2025 | Purified Cortrophin Gel |
| Astellas Pharma US INC | $34.54 | 2023-2024 | Izervay |
| Eyepoint US, INC. | $28.54 | 2019 | |
| Iridex Corporation | $28.24 | 2019 | |
| Horizon Therapeutics Plc | $25.03 | 2019 | |
| Genentech USA, INC. | $23.53 | 2025 | Vabysmo |
| Ivantis, INC | $21.03 | 2019 | |
| Topcon Healthcare, INC. | $20.68 | 2021 | |
| Rayner Intraocular Lenses Limited | $20.35 | 2022 | |
| Amgen INC. | $17.63 | 2025 | Tepezza |
| Alexion Pharmaceuticals, INC. | $14.50 | 2020 | |
| Beaver-Visitec International, INC. | $14.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harjit Athwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.